In the EU, rare diseases that are also life-threatening or chronically debilitating with a low prevalence and a high level of complexity are defined as orphan diseases.
Healthcare biotechnology refers to a medicinal or diagnostic product or a vaccine that consists o
Yes, the Orphan Drug Regulation 141/2000 cam
Both patients and the public have to be regularly informed about what the use and procedures of H
Some 20-30 million Europeans are affected by rare diseases.